Qube Research & Technologies (QRT)
INSM icon

Qube Research & Technologies (QRT)’s Insmed INSM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179M Buy
1,682,334
+1,533,819
+1,033% +$186M 0.17% 143
2026
Q1 		$24.3M Buy
+148,515
New +$22.8M 0.03% 772
2025
Q4 		– Sell
-1,544,315
Closed -$222M – 3863
2025
Q3 		$222M Buy
1,544,315
+462,265
+43% +$56.6M 0.23% 84
2025
Q2 		$109M Buy
+1,082,050
New +$82.7M 0.11% 228
2025
Q1 		– Sell
-389,033
Closed -$26.9M – 3677
2024
Q4 		$26.9M Sell
389,033
-100,274
-20% -$7.22M 0.04% 594
2024
Q3 		$35.7M Buy
+489,307
New +$36.1M 0.05% 445
2024
Q2 		– Sell
-153,402
Closed -$4.16M – 4256
2024
Q1 		$4.16M Buy
153,402
+133,005
+652% +$3.72M 0.01% 1345
2023
Q4 		$632K Buy
+20,397
New +$529K ﹤0.01% 2160
2022
Q4 		– Sell
-121,597
Closed -$2.62M – 2728
2022
Q3 		$2.62M Buy
+121,597
New +$2.92M 0.02% 820

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INSM Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Insmed (INSM) stake by 1,033% in Q2 2026, buying an estimated $186M and bringing the position to 1,682,334 shares worth $179M. The position accounts for 0.17% of the portfolio, ranked #143.

Qube Research & Technologies (QRT) first reported a position in INSM in Q3 2022 and has held it in 9 quarters since. The position peaked at $222M in Q3 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,682,334 shares of Insmed worth $179M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 1,533,819 Insmed shares in Q2 2026, an estimated $186M.
  • Insmed made up 0.17% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #143 holding.
  • Qube Research & Technologies (QRT) first reported a position in Insmed in Q3 2022 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Insmed position peaked at $222M in Q3 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.